Moderna, Inc. vs PayPal Holdings, Inc. — how do they compare? Moderna, Inc. trades at $60.83 (market cap $23.88B), while PayPal Holdings, Inc. trades at $58.17 (market cap $50.53B). The key difference: PayPal Holdings, Inc. is far larger — about 2.1× Moderna, Inc.'s market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PYPL | |
|---|---|---|
Market Cap | $23.88B | $50.53B |
Sector | Health | Financials |
52-Week High | $81.80 | $76.13 |
52-Week Low | $22.36 | $39.08 |
Enterprise Value | $20.03B | $52.68B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →